Reading firm Osborne Clarke at centre of £80million life science deal
Reading law firm Osborne Clarke have helped secure Series C equity funding of £71million for health tech platform Proximie.
Lead investors in the funding round were Advent Life Sciences.
Formed in 2009, Advent Life Sciences invest principally in medtech, drug research and enabling technologies, and medtech, the firm is active in the UK, US, and France.
Read more - Swindon's Landhawk Software purchased by The Idox Group
Existing investors F-Prime Capital, Eight Roads, Questa Capital, Global Ventures, and Maverick Ventures also participated in the round.
Advent were joined in the funding round by new investors Emerson Collective, the impact investor founded by Laurene Powell Jobs as well as SoftBank Vision 2, British Patient Capital, Mubadala Investment Company and the Minderoo Foundation.
Proximie is a tool allowing surgeons to virtually “scrub in” to any operating room in the world, extending the capabilities of surgeons to areas without access to top surgical care. It was launched in 2016.
The capital raised will provide the Proximie platform with ability to accelerate product and service development, develop their marketplace ecosystem and scale its centralised platform delivering connected surgical care.
The Osborne Clarke team assisting Advent Life Sciences was led by partner Justin Starling, who was supported by associate director Robert Pook and associate Chris Flach. The team behind the deal are based in the firm’s Reading office.
The team advises at every stage of company development across all corporate issues, from equity and debt fundraisings to M&A, IPOs and JVs.
Read more - South Coast Property Awards 2022 - Gallery